2031 年体外膜氧合市场报告(细分市场、地域、动态、最新发展和战略见解)

  • Report Code : TIPHE100001219
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Extracorporeal Membrane Oxygenation Market Forecast by 2031

Buy Now

体外膜氧合市场规模预计将从 2023 年的 5.8 亿美元增至 2031 年的 7.4 亿美元。预计 2023-2031 年市场复合年增长率为 3.10%。产品开发和审批的激增可能仍将是市场的主要趋势。

体外膜氧合市场分析

2020 年,全球缺血性中风病例为 8910 万例,中风病例为 6820 万例。北美的心血管疾病病例更多。在全球范围内,心脏病越来越普遍,发达国家的发病率急剧上升。生活方式和其他健康问题的改变导致发病率上升。由于新产品的发布、技术的进步以及大量人群面临心血管疾病风险,市场预计将增长。Terumo Group、Medtronic Plc、MicroPort Scientific Corporation、LivaNova Plc、Nioro Medical Corporation、Getinge AB、Braile Biomedica、Fresenius Medical Care AG & Co KGaA、Abiomed Inc. 等公司构成了体外膜氧合 (ECMO) 市场的大部分份额。

体外膜氧合市场概况

呼吸衰竭可能是由慢性阻塞性肺病 (COPD) 引起的气流阻塞引起的。它是导致全球数百万人死亡的严重疾病之一。世界卫生组织 (WHO) 报告称,2019 年全球有 323 万人死于 COPD,使其成为 2022 年第三大死亡原因。大约 90% 的 COPD 死亡发生在中低收入国家。根据美国疾病控制和预防中心 (CDC) 的数据,2020 年,COPD 是美国第六大死亡原因。因此,由于呼吸衰竭和心血管疾病的发病率不断上升,ECMO 市场正在增长。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

体外膜氧合市场:

体外膜氧合市场
  • Extracorporeal Membrane Oxygenation Market
    复合年增长率(2023 - 2031)
    3.10%
  • 2023 年市场规模
    5.8 亿美元
  • 2031年市场规模
    7.4亿美元

市场动态

增长动力
  • ECMO 在肺移植手术中的日益普及有利于市场增长
未来趋势
  • 产品开发和审批激增
机会
  • ECMO 提高存活率将创造巨大市场机遇

关键人物

  • 泰尔茂集团 Group
  • 美敦力公司
  • 微创医疗科学有限公司
  • 利瓦诺瓦公司 Plc
  • 尼普洛医疗公司
  • 欧罗塞斯有限公司 S.R.L.
  • 洁定公司
  • 布莱尔生物医药公司
  • 费森尤斯医药公司

区域概况

Extracorporeal Membrane Oxygenation Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Extracorporeal Membrane Oxygenation Market情态
  • 静脉动脉体外膜肺氧合
  • 静脉-体外膜肺氧合
  • 动静脉体外膜肺氧合
Extracorporeal Membrane Oxygenation Market应用
  • 呼吸和心脏病学
Extracorporeal Membrane Oxygenation Market年龄组
  • 成年人
  • 儿科
  • 新生儿
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

体外膜氧合市场驱动因素和机遇

ECMO 在肺移植手术中的日益普及有利于市场增长

对于患有囊性纤维化、特发性肺纤维化 (IPF) 和 COPD 等终末期肺病的患者,肺移植是一种可以提高生活质量的救命治疗选择。ECMO 是一种灵活的仪器,可用于肺移植术前、术中和术后阶段。它是接受肺移植的患者的过渡期。因此,ECMO 在肺移植中的应用正在迅速扩大,用于治疗肺部疾病对其生命构成严重威胁的患者。移植受体科学登记处 (SRTR) 报告称,全球每年约进行 4,600 例肺移植,其中北美占 55%。同一消息来源称,在美国,有 3,243 名患者被列入候补名单,约有 2,759 名患者接受了肺移植。肺移植后,最常见的死亡原因是原发性移植物功能障碍 (PGD)。

因此,肺移植后的 PGD 倒数第二阶段采用 ECMO 治疗。根据美国国家医学图书馆 (NLM) 2022 年的数据,PGD 的总体发病率为 30%。这种情况的风险因素包括器官获取、保存方法、术中器官植入和再灌注以及术前供体肺缺血。因此,对 ECMO 设备治疗 PGD 患者的需求日益增加。

ECMO 提高存活率将创造巨大市场机遇

由于 ECMO 治疗提高了存活率,最近使用 ECMO 治疗呼吸衰竭的情况有所增加。2021 年,BioMed Central 的一项研究报告称,呼吸衰竭并接受静脉-静脉体外膜氧合 (VV ECMO) 的 COVID-19 患者的存活率为 60%。此外,由于它可以提高患者的存活率,因此建议对急性呼吸窘迫综合征 (ADRS)、肺移植后原发性移植物功能障碍和肺创伤患者使用 ECMO。此外,ECMO 还可以提高心脏骤停后治疗方案受到影响的患者的存活率。西方生活方式的彻底改变导致了多种心脏病。这促使主要参与者进行大量研发投资,从而提高了 ECMO 治疗的有效性并提高了存活率。因此,由于在各种治疗中使用 ECMO 的存活率不断提高,预计预测期内将有更多的市场机会。

体外膜氧合市场报告细分分析

有助于得出体外膜氧合市场分析的关键部分是方式、应用和年龄组。

  • 根据方式,体外膜氧合市场细分为静脉动脉体外膜氧合、静脉静脉体外膜氧合和动静脉体外膜氧合。 2023 年,静脉动脉体外膜氧合细分市场占有最大的市场份额。
  • 根据应用,市场分为呼吸科和心脏病科。2023 年,呼吸科占据了最大的市场份额。
  • 根据年龄组,市场分为成人、儿科和新生儿。成人市场在 2023 年占据了相当大的市场份额。

体外膜氧合市场份额地域分析

体外膜氧合市场报告的地理范围主要分为五个区域:北美、亚太、欧洲、中东和非洲、南美和中美。

北美体外膜氧合市场分为美国、加拿大和墨西哥。重要市场参与者的存在以及越来越多的产品发布和批准是该地区市场增长的重要因素。此外,心血管疾病和呼吸系统疾病的日益流行可能有利于市场增长

体外膜氧合市场报告范围

报告属性细节
2023 年的市场规模5.8亿美元
2031 年市场规模7.4亿美元
全球复合年增长率(2023 - 2031)3.10%
史料2021-2022
预测期2024-2031
涵盖的领域按方式
  • 静脉动脉体外膜肺氧合
  • 静脉-体外膜肺氧合
  • 动静脉体外膜肺氧合
按应用
  • 呼吸和心脏病学
按年龄组
  • 成年人
  • 儿科
  • 新生儿
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 泰尔茂集团
  • 美敦力公司
  • 微创医疗科学有限公司
  • 利瓦诺瓦公司
  • 尼普洛医疗公司
  • 欧罗塞斯有限公司
  • 洁定公司
  • 布莱尔生物医药公司
  • 费森尤斯医药公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

体外膜氧合市场新闻和最新发展

体外膜氧合市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。下面列出了体外膜氧合市场的一些发展情况:

  • 市场领先的医疗技术和创新公司 LivaNova PLC 宣布,该公司的下一代高级循环支持 (ACS) 泵和控制器系统 LifeSPARC 已获得美国食品药品管理局 (FDA) 颁发的体外膜氧合 (ECMO) 510(k) 许可。LivaNova 利用现有的现实世界证据(包括在 COVID-19 疫情期间收集的数据)获得了这一新适应症。(来源:LivaNova PLC,新闻稿,2022 年 11 月)
  • Inspira Technologies OXY BHN Ltd. 推出了“Liby™”系统,这是一种先进的生命支持形式,医疗行业更熟悉的名称是体外膜氧合 (ECMO),用于治疗危及生命的心肺衰竭患者。(来源:Inspira Technologies,新闻稿,2022 年 7 月)

体外膜氧合市场报告覆盖范围和交付成果

“体外膜氧合市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 体外膜氧合市场规模及全球、区域和国家层面所有主要细分市场的预测
  • 体外膜氧合市场趋势以及市场动态,如驱动因素、限制因素和关键机遇
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 体外膜氧合市场分析涵盖主要市场趋势、全球和区域框架、主要参与者、法规和最新的市场发展。
  • 行业格局和竞争分析,涵盖市场集中度、热图分析、知名参与者以及体外膜氧合市场的最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the extracorporeal membrane oxygenation market?

The market is expected to register a CAGR of 3.10% during 2023–2031.

Which are the leading players operating in the extracorporeal membrane oxygenation market?

Terumo Group, Medtronic Plc, Braile Biomedica, LivaNova Plc, Nipro Medical Corporation, MicroPort Scientific Corporation, Eurosets S.R.L., Getinge AB, Fresenius Medical Care AG & Co KGaA

What are the future trends of the extracorporeal membrane oxygenation market?

Surging product developments and approvals will likely remain a key trend in the market.

What are the driving factors impacting the extracorporeal membrane oxygenation market?

Key factors driving the market are the increasing prevalence of cardiovascular diseases and respiratory failures and the growing adoption of ECMO in lung transplantation procedures.

Which region dominated the extracorporeal membrane oxygenation market in 2023?

North America dominated the extracorporeal membrane oxygenation market in 2023

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Medical Device : READ MORE..